Briakinumab Biosimilar - Research Grade
Product Specifications
Specifications
Detects human CD30
Target
CD30
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
AB1436 20 mg
Rel- (8R,8'R) -dimethyl- (7S,7'R) -bis (3,4-methylenedioxyphenyl) tetrahydro-furan
Ask
View Details 247693-AP 100 µL
IRAK3 (Interleukin-1 Receptor-Associated Kinase 3, ASRT5, FLJ13601, IRAK-M, IRAKM) (AP) discontinued
Ask
View Details 
MBS1224501-01 0.02 mg (E-Coli)
Recombinant Influenza A virus Non-structural protein 1 (NS)
Ask
View Details MBS1224501-02 0.1 mg (E-Coli)
Recombinant Influenza A virus Non-structural protein 1 (NS)
Ask
View Details 
MBS1224501-03 0.02 mg (Yeast)
Recombinant Influenza A virus Non-structural protein 1 (NS)
Ask
View Details